Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
11.49
+0.04 (0.35%)
Apr 30, 2026, 3:04 PM CST

SHE:301211 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
4,7985,1036,1236,2648,3169,026
Market Cap Growth
-12.36%-16.66%-2.25%-24.68%-7.87%-
Enterprise Value
3,2613,5364,5114,4166,4278,614
Last Close Price
11.4912.2214.4614.3818.8620.20
PE Ratio
143.63146.1866.8835.5766.1174.20
PS Ratio
10.4511.2613.739.4516.1516.70
PB Ratio
2.102.252.652.663.654.06
P/TBV Ratio
2.172.312.732.743.774.19
P/FCF Ratio
----47.5687.71
P/OCF Ratio
-675.8363.7345.7033.1672.80
EV/Sales Ratio
7.107.8010.126.6612.4815.93
EV/EBITDA Ratio
66.8184.1984.0326.6667.1462.68
EV/EBIT Ratio
--152.2030.3785.2972.96
EV/FCF Ratio
-71.31---36.7683.70
Debt / Equity Ratio
0.000.000.000.000.00-
Debt / EBITDA Ratio
0.050.070.090.040.08-
Debt / FCF Ratio
----0.04-
Net Debt / Equity Ratio
-0.67-0.68-0.71-0.77-0.86-0.84
Net Debt / EBITDA Ratio
-32.29-36.95-30.39-10.97-20.42-13.53
Net Debt / FCF Ratio
33.6334.6623.8736.73-11.18-18.07
Asset Turnover
0.190.190.180.260.210.35
Inventory Turnover
2.812.752.042.763.623.20
Quick Ratio
15.7614.4310.4710.8610.0119.65
Current Ratio
17.1815.6411.4011.9810.6620.67
Return on Equity (ROE)
1.47%1.52%3.92%7.60%5.59%8.32%
Return on Assets (ROA)
0.02%-0.01%0.74%3.60%1.95%4.71%
Return on Invested Capital (ROIC)
0.10%-0.02%4.44%29.32%18.58%28.75%
Return on Capital Employed (ROCE)
0.00%0.00%1.30%6.10%3.30%5.30%
Earnings Yield
0.70%0.68%1.49%2.81%1.51%1.35%
FCF Yield
-0.95%-0.88%-1.12%-0.79%2.10%1.14%
Dividend Yield
0.52%0.49%1.73%2.30%1.22%0.85%
Payout Ratio
213.00%206.24%151.00%54.51%57.24%-
Buyback Yield / Dilution
4.19%-4.87%0.60%-0.97%-33.19%1.01%
Total Shareholder Return
4.72%-4.38%2.33%1.33%-31.97%1.86%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.